Kishbauch was 63, which is not that old for a CEO. Under the circumstances, it seems reasonable to infer that ACHN’s incessant predictions of a major HCV partnership were exaggerated.
The new CEO is Milind Deshpande, 55, who had been CSO.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”